← Back to Search

Dental hygiene procedures for Peri-Implantitis

Waitlist Available
Led By Georgios Kotsakis, DDS, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is the subject ≥ 25 years of age?
Is the subject committed to the study and the required follow-up visits?
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing whether particles released from dental implants are associated with peri-implantitis, and if so, what triggers this release and how it amplifies peri-implant inflammation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
The subject is at least 25 years old.
Yes, the subject is committed to the study and the required follow-up visits.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks +/- 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks +/- 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Titanium Dissolution
Secondary outcome measures
Expression of pro-inflammatory cytokines in response to titanium

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Implant-specific treatmentExperimental Treatment2 Interventions
Implant brush
Group II: Tooth-borne treatmentActive Control2 Interventions
Titanium curettes
First Studied
Drug Approval Stage
How many patients have taken this drug
Peri-implantitis debridement

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,721 Previous Clinical Trials
1,819,168 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis
Royalty Research Fund - University of WashingtonOTHER
1 Previous Clinical Trials
148 Total Patients Enrolled
Georgios Kotsakis, DDS, MSPrincipal InvestigatorUTHealth San Antonio
1 Previous Clinical Trials
34 Total Patients Enrolled
1 Trials studying Peri-Implantitis
34 Patients Enrolled for Peri-Implantitis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current enrolment opportunities for this research project?

"According to the clinicaltrials.gov entry, this clinical trial is currently enrolling patients and has been active since November 22nd 2017 with its most recent edit taking place on November 2nd 2020."

Answered by AI

What is the total recruitment rate for this medical study?

"Indeed, the clinicaltrials.gov listing states that this trial is presently in search of participants. This research project was initially made available on November 22nd 2017 with a most recent edit date of November 2nd 2020 and seeks to enrol 30 patients across one medical facility."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
UTHealth San Antonio
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Most responsive sites:
  1. UTHealth San Antonio: < 48 hours
Average response time
  • < 2 Days
~5 spots leftby Feb 2025